A Model to Evaluate the Cytotoxicity of the Fungal Volatile Organic Compound 1-octen-3-ol in Human Embryonic Stem Cells

Mycopathologia

Volumn 173, Issue 1, 2012, Pages 13-20

  Inamdar, Arati A ^a   Moore, Jennifer C ^a   Cohen, Rick I ^a   Bennett, Joan Wennstrom ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

1 octen 3 ol; Building related illness; Fungal volatile organic compounds (VOCs); Human embryonic stem cells (hESCs); Mushroom alcohol

Indexed keywords

1 OCTEN 3 OL; 1-OCTEN-3-OL; OCTANOL; VOLATILE ORGANIC COMPOUND;

ARTICLE; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; EMBRYONIC STEM CELL; HUMAN; IC 50;

CELL SURVIVAL; CELLS, CULTURED; EMBRYONIC STEM CELLS; HUMANS; INHIBITORY CONCENTRATION 50; OCTANOLS; VOLATILE ORGANIC COMPOUNDS;

BASIDIOMYCOTA;

EID: 82355175962     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-011-9457-z     Document Type: Article

References (45)

1. Institute of Medicine of the National Academies. Damp indoor spaces and health. Washington, DC: Institute of Medicine of the National Academies, The National Academies Press; 2004.
2. World Health Organization (WHO). Guidelines for indoor air quality: dampness and mould. Germany: Druckartner Moser; 2009.
3. Hodgson MJ. Sick building syndrome. Occup Med. 2000; 15: 571-85.
4. Straus DC. Molds, mycotoxins, and sick building syndrome. Toxicol Ind Health. 2009; 25: 617-35.
5. Burge PS. Studies on the role of fungi in sick building syndrome. Occup Environ Med. 2004; 61: 185-90.
6. Kilburn KH. Role of molds and mycotoxins in being sick in buildings: neurobehavioral and pulmonary impairment. Adv Appl Microbiol. 2004; 55: 339-59.
7. Empting LD. Neurologic and neuropsychiatric syndrome features of mold and mycotoxin exposure. Toxicol Ind Health. 2009; 25: 577-81.
8. Thrasher JD, Crawley S. The biocontaminants and complexity of damp indoor spaces: more than what meets the eye. Toxicol Ind Health. 2009; 25: 583-615.
9. Robbins CA, Swenson LJ, Nealley ML, Kelman BJ, Gots RE. Health effects of mycotoxins in indoor air: a critical review. Appl Occup Environ Hyg. 2000; 15: 773-84.
10. Skaug MA, Eduard E, Stormer FC. Ochratoxin A in airborne dust and fungal conidia. Mycopathologia. 2000; 151: 93-8.
11. Rao CY, Burge HA, Brain JD. The time course of responses to intratracheally instilled toxic Stachybotrys chartarum spores in rats. Mycopathologia. 2000; 149: 27-34.
12. Karunasena E, Larrañaga MD, Simoni JS, Douglas DR, Straus DC. Building-associated neurological damage modeled in human cells: a mechanism of neurotoxic effects by exposure to mycotoxins in the indoor environment. Mycopathologia. 2010; 170: 377-90.
13. Hardin BD, Kelman BJ, Saxon A. Adverse human health effects associated with molds in the indoor environment. J Occup Environ Med. 2003; 45: 470-8.
14. Mølhave L. Volatile organic compounds and the sick building syndrome. In: Lipmann M, editor. Environmental toxicants: human exposures and their health effects. New York: Wiley-Interscience; 2009. p. 241-56.
15. Claeson AS, Nordin S, Sunesson AL. Effects on perceived air quality and symptoms of exposure to microbially produced metabolites and compounds emitted from damp building materials. Indoor Air. 2007; 19: 102-12.
16. Körpi A, Järnberg J, Pasanen AL. Microbial volatile organic compounds. Crit Rev Toxicol. 2009; 39: 139-93.
17. Tressl R, Bahri D, Engel KH. Formation of eight-carbon and ten-carbon components in mushrooms (Agaricuscampestris). J Agric Food Chem. 1982; 30: 89-93.
18. Assaf S, Hadar Y, Dosoretz CG. 1-Octen-3-ol and 13-hydroperoxylinoleate are products of distinct pathways in the oxidative breakdown of linoleic acid by Pleurotuspulmonarius. Enzyme Microb Technol. 1997; 21: 484-90.
19. Kaminski E, Stawicki S, Wasowicz E. Volatile flavor compounds produced by molds of Aspergillus, Penicillium, and Fungiimperfecti. Appl Microbiol. 1974; 27: 1001-4.
20. Sunesson AL, Nilsson CA, Andersson B, Blomquist G. Volatile metabolites produced by two fungal species cultivated on building materials. Ann Occup Hyg. 1996; 40: 397-410.
21. Claeson AS, Levin JO, Blomquist G, Sunesson AL. Volatile metabolites from microorganisms grown on humid building materials and synthetic media. J Environ Monit. 2002; 4: 667-72.
22. Matysik S, Herbarth O, Mueller A. Determination of volatile metabolites originating from mould growth on wall paper and synthetic media. J Microbiol Methods. 2008; 75: 182-7.
23. Moularat S, Robine E, Ramalho O, Oturan MA. Detection of fungal development in a closed environment through the identification of specific VOC: demonstration of a specific VOC fingerprint for fungal development. Sci Total Environ. 2008; 407: 139-46.
24. Mosandl A, Heusinger G, Gessner M. Analytical and sensory differentiation of 1-octen-3-ol enantiomers. J Agric Food Chem. 1986; 34: 119-22.
25. Combet E, Henderson J, Eastwood DC, Burton KS. Eight-carbon volatiles in mushrooms and fungi: properties, analysis, and biosynthesis. Mycoscience. 2006; 47: 317-26.
26. Inamdar AA, Masurekar P, Bennett JW. Neurotoxicity of fungal volatile organic compounds in Drosophilamelanogaster. Toxicol Sci. 2010; 117: 418-26.
27. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282: 1145-7.
28. Bakand S, Winder C, Khalil C, Hayes A. A novel in vitro exposure technique for toxicity testing of selected volatile organic compounds. J Environ Monit. 2006; 8: 100-5.
29. Shen S, Yuan L, Zeng S. An effort to test the embryotoxicity of benzene, toluene, xylene, and formaldehyde to murine embryonic stem cells using airborne exposure technique. Inhal Toxicol. 2009; 21: 973-8.
30. Moore JC, Sadowy S, Alikani M, Toro-Ramos AJ, Swerdel MR, Hart RP, Cohen RI. A high-resolution molecular-based panel of assays for identification and characterization of human embryonic stem cell line. Stem Cell Res. 2010; 4: 92-106.
31. Wilson AP. Cytotoxicity and viability assays. In: Masters JRW, editor. Animal cell culture. NewYork: Oxford University Press; 2000. pp. 175-219.
32. Chen Y, Lewis W, Diwan A, Cheng EH, Matkovich SJ, Dorn GW 2nd. Dual autonomous mitochondrial cell death pathways are activated by Nix/BNip3L and induce cardiomyopathy. Proc Natl Acad Sci USA. 2010; 107: 9035-42.
33. Chapin RE, Stedman DB. Endless possibilities: stem cells and the vision for toxicology testing in the 21st century. Toxicol Sci. 2009; 112: 17-22.
34. Davila JC, Cezar GG, Thiede M, Strom S, Miki T, Trosko J. Use and application of stem cells in toxicology. Toxicol Sci. 2004; 79: 214-23.
35. EPA (U. S. Environmental Protection Agency) http://www. epa. gov/oppbppd1/biopesticides/ingredients/factsheets/factsheet_069037-069038. htm.
36. Kreja L, Seidel HJ. Evaluation of the genotoxic potential of some microbial volatile organic compounds (MVOC) with the comet assay, the micronucleus assay and the HPRT gene mutation assay. Mutat Res. 2002; 513: 143-50.
37. Kreja L, Seidel HJ. On the cytotoxicity of some microbial volatile organic compounds as studied in the human lung cell line A549. Chemosphere. 2002; 49: 105-10.
38. Ström G, West J, Wess′en B, Palmgren U. Quantitative analysis of microbial volatiles in damp Swedish houses. In: Samson RA, Flannigan B, Flannigan ME, Verhoeff AP, Adan OCG, Hoekstra ES, Editors. Health implications of fungi in indoor environments. Air quality monographs, vol 2. Amsterdam: Elsevier Science; 1994. pp. 291-305.
39. Schleibinger H, Laussmann D, Bornehag CG, Eis D, Rueden H. Microbial volatile organic compounds in the air of moldy and mold-free indoor environments. Indoor Air. 2008; 18: 113-24.
40. Morey PA, Wortham A, Weber E, Horner M, Black Muller W. Microbial VOCs in moisture damaged buildings. Healthy Buildings. 1997; 1: 245-50.
41. Kim JL, Elfman L, Mi Y, Wieslander G, Smedje G, Norbäck D. Indoor molds, bacteria, microbial volatile organic compounds and plasticizers in schools-associations with asthma and respiratory symptoms in pupils. Indoor Air. 2007; 17: 153-63.
42. Wålinder R, Ernstgård L, Norbäck D, Wieslander G, Johanson G. Acute effects of 1-octen-3-ol, a microbial volatile organic compound (MVOC)-an experimental study. Toxicol Lett. 2008; 181: 141-7.
43. ATSDR (Agency for Toxic Substances and Disease Registry) http://www. atsdr. cdc. gov/toxfaqs/tf. asp?id=160&tid=29.
44. EPA (Environmental and Protection Agency) http://www. epa. gov/ttn/atw/hlthef/toluene. html#ref2.
45. Maier NM, Franco P, Lindner W. Separation of enantiomers: needs, challenges, perspectives. J Chromatogr. 2001; 906: 3-33.